BACKGROUND AND OBJECTIVE: A single session of repetitive transcranial magnetic stimulation (rTMS) over motor cortex had been reported to produce short term relief of some types of chronic pain. The present study investigated whether five consecutive days of rTMS would lead to longer lasting pain relief in unilateral chronic intractable neuropathic pain. PATIENTS AND METHODS: Forty eight patients with therapy resistant chronic unilateral pain syndromes (24 each with trigeminal neuralgia (TGN) and post-stroke pain syndrome (PSP)) participated. Fourteen from each group received 10 minutes real rTMS over the hand area of motor cortex (20 Hz, 10x10 s trains, intensity 80% of motor threshold) every day for five consecutive days. The remaining patients received sham stimulation. Pain was assessed using a visual analogue scale (VAS) and the Leeds assessment of neuropathic symptoms and signs (LANSS) scale, before, after the first, fourth, and fifth sessions, and two weeks after the last session. RESULTS: No significant differences were found in basal pain ratings between patients receiving real- and sham-rTMS. However, a two factor ANOVA revealed a significant "+/- TMS" x "time" interaction indicating that real and sham rTMS had different effects on the VAS and LANSS scales. Post hoc testing showed that in both groups of patients, real-rTMS led to a greater improvement in scales than sham-rTMS, evident even two weeks after the end of the treatment. No patient experienced adverse effects. CONCLUSION: These results confirm that five daily sessions of rTMS over motor cortex can produce longlasting pain relief in patients with TGN or PSP.
RCT Entities:
BACKGROUND AND OBJECTIVE: A single session of repetitive transcranial magnetic stimulation (rTMS) over motor cortex had been reported to produce short term relief of some types of chronic pain. The present study investigated whether five consecutive days of rTMS would lead to longer lasting pain relief in unilateral chronic intractable neuropathic pain. PATIENTS AND METHODS: Forty eight patients with therapy resistant chronic unilateral pain syndromes (24 each with trigeminal neuralgia (TGN) and post-stroke pain syndrome (PSP)) participated. Fourteen from each group received 10 minutes real rTMS over the hand area of motor cortex (20 Hz, 10x10 s trains, intensity 80% of motor threshold) every day for five consecutive days. The remaining patients received sham stimulation. Pain was assessed using a visual analogue scale (VAS) and the Leeds assessment of neuropathic symptoms and signs (LANSS) scale, before, after the first, fourth, and fifth sessions, and two weeks after the last session. RESULTS: No significant differences were found in basal pain ratings between patients receiving real- and sham-rTMS. However, a two factor ANOVA revealed a significant "+/- TMS" x "time" interaction indicating that real and sham rTMS had different effects on the VAS and LANSS scales. Post hoc testing showed that in both groups of patients, real-rTMS led to a greater improvement in scales than sham-rTMS, evident even two weeks after the end of the treatment. No patient experienced adverse effects. CONCLUSION: These results confirm that five daily sessions of rTMS over motor cortex can produce longlasting pain relief in patients with TGN or PSP.
Authors: L García-Larrea; R Peyron; P Mertens; M C Gregoire; F Lavenne; D Le Bars; P Convers; F Mauguière; M Sindou; B Laurent Journal: Pain Date: 1999-11 Impact factor: 6.961
Authors: J D Rollnik; T J Huber; H Mogk; S Siggelkow; S Kropp; R Dengler; H M Emrich; U Schneider Journal: Neuroreport Date: 2000-12-18 Impact factor: 1.837
Authors: P Mertens; C Nuti; M Sindou; M Guenot; R Peyron; L Garcia-Larrea; B Laurent Journal: Stereotact Funct Neurosurg Date: 1999 Impact factor: 1.875
Authors: M S George; E M Wassermann; T A Kimbrell; J T Little; W E Williams; A L Danielson; B D Greenberg; M Hallett; R M Post Journal: Am J Psychiatry Date: 1997-12 Impact factor: 18.112
Authors: J P Nguyen; J P Lefaucheur; P Decq; T Uchiyama; A Carpentier; D Fontaine; P Brugières; B Pollin; A Fève; S Rostaing; P Cesaro; Y Keravel Journal: Pain Date: 1999-09 Impact factor: 6.961
Authors: J P Nguyen; J P Lefaucher; C Le Guerinel; J F Eizenbaum; N Nakano; A Carpentier; P Brugières; B Pollin; S Rostaing; Y Keravel Journal: Arch Med Res Date: 2000 May-Jun Impact factor: 2.235
Authors: H R Siebner; J M Tormos; A O Ceballos-Baumann; C Auer; M D Catala; B Conrad; A Pascual-Leone Journal: Neurology Date: 1999-02 Impact factor: 9.910
Authors: Alex W Thomas; Karissa Graham; Frank S Prato; Julia McKay; Patricia Morley Forster; Dwight E Moulin; Sesh Chari Journal: Pain Res Manag Date: 2007 Impact factor: 3.037
Authors: Raffaele Nardone; Yvonne Höller; Stefan Leis; Peter Höller; Natasha Thon; Aljoscha Thomschewski; Stefan Golaszewski; Francesco Brigo; Eugen Trinka Journal: J Spinal Cord Med Date: 2013-11-26 Impact factor: 1.985